Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3305)
All Articles published online
|
Nov 28, 2009 (publication date) through Nov 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Leu JD, Lin IF, Sun YF, Chen SM, Liu CC, Lee YJ. Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population. World J Gastroenterol 2009; 15(44): 5592-5597 [PMID: 19938200 DOI: 10.3748/wjg.15.5592] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i44/5592.htm |
| Number | Citing Articles |
| 1 |
Yun Yang, Tian Xia, Ning Li, Jin Zhang, Yuan Yang, Wenming Cong, Qiang Deng, Ke Lan, Weiping Zhou. Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma. Protein & Cell 2013; 4(1): 71 doi: 10.1007/s13238-012-2067-9
|
| 2 |
Yubin Liu, Sujuan Kuang, Jun Zheng, Jianghua Zheng, Haosheng Jin, Sicong Chen, Zhixiang Jian. Murine double minute 2 rs2279744 polymorphism and hepatocellular carcinoma risk in East Asians: a meta-analysis. Tumor Biology 2014; 35(2): 961 doi: 10.1007/s13277-013-1128-x
|
| 3 |
Xi Wang, Xuelong Zhang, Bing Qiu, Yinhua Tang, He Sun, Hongfei Ji, Yan Liu, Lijun Shi, Guang Song, Youlin Yang. MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus‐related hepatocellular carcinoma in a northeast Han Chinese population. Liver International 2012; 32(7): 1172 doi: 10.1111/j.1478-3231.2012.02787.x
|
| 4 |
Yan Wan, Wei Wu, Zhihua Yin, Peng Guan, Baosen Zhou. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-208
|
| 5 |
Tao Tang, Xin Song, Zhiying Yang, Linping Huang, Wenyue Wang, Haidong Tan. Association between murine double minute 2 T309G polymorphism and risk of liver cancer. Tumor Biology 2014; 35(11): 11353 doi: 10.1007/s13277-014-2432-9
|
| 6 |
Hikmet Akkız, Ahmet Taner Sümbül, Süleyman Bayram, Aynur Bekar, Ersin Akgöllü. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. Cancer Epidemiology 2010; 34(4): 448 doi: 10.1016/j.canep.2010.04.008
|
| 7 |
Hong-Bo Ma, Tao Huang, Feng Han, Wei-Yu Chen. Association Between MDM2 Promoter SNP309 T/G Polymorphism and Liver Cancer Risk - a Meta-analysis. Asian Pacific Journal of Cancer Prevention 2012; 13(6): 2841 doi: 10.7314/APJCP.2012.13.6.2841
|
| 8 |
Li-Hung Tsai, Chang-Ming Lin, Shu-Chen Chiang, Chia-Ling Chen, Su-Jane Lan, Lai-Chu See. Symptoms and Distress Among Patients With Liver Cirrhosis but Without Hepatocellular Carcinoma in Taiwan. Gastroenterology Nursing 2014; 37(1): 49 doi: 10.1097/SGA.0000000000000020
|
| 9 |
Valeria Di Vuolo, Luigi Buonaguro, Francesco Izzo, Simona Losito, Gerardo Botti, Franco M Buonaguro, Maria Lina Tornesello. TP 53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients. Infectious Agents and Cancer 2011; 6(1) doi: 10.1186/1750-9378-6-13
|
| 10 |
Uirá Fernandes TEIXEIRA, Andréa Gomes Coelho IZAGUIRRE, Mayara Christ MACHRY, Carlos Thadeu CERSKI, Ajácio Bandeira de Mello BRANDÃO, Paulo Roberto Ott FONTES. ASSOCIATION BETWEEN MURINE DOUBLE MINUTE 2 - T309G polymorphism and recurrence of hepatocellular carcinoma after surgical treatment. Arquivos de Gastroenterologia 2015; 52(4): 325 doi: 10.1590/S0004-28032015000400014
|
| 11 |
Neha Merchant, Sai Samyuktha Bandaru, Afroz Alam, L.V.K.S. Bhaskar. The correlation between MDM2 SNP309 T > G polymorphism and hepatocellular carcinoma risk – A meta-analysis. Human Gene 2022; 34: 201087 doi: 10.1016/j.humgen.2022.201087
|
| 12 |
Fei Jin, Wen-Jian Xiong, Jia-Chen Jing, Zhen Feng, Li-Shuai Qu, Xi-Zhong Shen. Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review. Journal of Cancer Research and Clinical Oncology 2011; 137(7): 1095 doi: 10.1007/s00432-010-0970-0
|
| 13 |
Guo-Yuan Liu, De-Ke Jiang, Su-Qin Shen, Long Yu. MDM2 SNP309T>G Polymorphism with Hepatocellular Carcinoma Risk: A Meta-analysis. Archives of Medical Research 2011; 42(2): 149 doi: 10.1016/j.arcmed.2011.02.002
|
| 14 |
Qiliu Peng, Xianjun Lao, Zhiping Chen, Hao Lai, Yan Deng, Jian Wang, Cuiju Mo, Jingzhe Sui, Junrong Wu, Limin Zhai, Shi Yang, Xue Qin, Shan Li, Qiliang Cai. TP53 and MDM2 Gene Polymorphisms, Gene-Gene Interaction, and Hepatocellular Carcinoma Risk: Evidence from an Updated Meta-Analysis. PLoS ONE 2013; 8(12): e82773 doi: 10.1371/journal.pone.0082773
|
| 15 |
Xiaoman Wo, Dong Han, Haiming Sun, Yang Liu, Xiangning Meng, Jing Bai, Feng Chen, Yang Yu, Yan Jin, Songbin Fu. MDM2 SNP309 contributes to tumor susceptibility: A meta-analysis. Journal of Genetics and Genomics 2011; doi: 10.1016/j.jgg.2011.07.005
|
| 16 |
Qi-Wen Chen, Hao Chen, Jian-Shan Cheng, Zhi-Qiang Meng. MDM2 SNP309T>G polymorphism and hepatocellular carcinoma risk: a meta-analysis. Tumor Biology 2014; 35(5): 4147 doi: 10.1007/s13277-013-1543-z
|
| 17 |
Xiaohua Duan, Jingquan Li. Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk. Medicine 2017; 96(36): e7856 doi: 10.1097/MD.0000000000007856
|
| 18 |
Moqin Qiu, Yingchun Liu, Xiangyuan Yu, Linyuan Qin, Chunhua Bei, Xiaoyun Zeng, Xiaoqiang Qiu, Bo Tang, Songqing He, Hongping Yu. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma. Tumor Biology 2016; 37(3): 3863 doi: 10.1007/s13277-015-4222-4
|